CIK 0001676725
- Large accelerated filer
IDEAYA Biosciences, Inc.
Sign in to watch- Ticker
- IDYA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 474268251
- Phone
- +1 650-443-6209
- Business address
- 5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $985,397
- in 1 filing, $985K under 10b5-1 plans
Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-24 | Lackner Mark SVP, Head of Biology | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2021-02-10 | Lackner Mark SVP, Head of Biology | Exercise or conversion | +596 | $6.98 | $4K | 596 |
| 2021-02-10 | Lackner Mark SVP, Head of Biology | Sale | −596 | $21.00 | $13K | 0 |
| 2021-02-10 | Lackner Mark SVP, Head of Biology | Exercise or conversion · Stock Option (right to buy) | −596 | 33,014 | ||
| 2021-02-09 | Lackner Mark SVP, Head of Biology | Exercise or conversion | +1,104 | $6.98 | $8K | 1,104 |
| 2021-02-09 | Lackner Mark SVP, Head of Biology | Sale | −1,104 | $21.05 | $23K | 0 |
| 2021-02-09 | Lackner Mark SVP, Head of Biology | Exercise or conversion · Stock Option (right to buy) | −1,104 | 33,610 | ||
| 2021-02-08 | Lackner Mark SVP, Head of Biology | Exercise or conversion | +300 | $6.98 | $2K | 300 |
| 2021-02-08 | Lackner Mark SVP, Head of Biology | Sale | −100 | $21.02 | $2K | 200 |
| 2021-02-08 | Lackner Mark SVP, Head of Biology | Sale | −200 | $21.00 | $4K | 0 |
| 2021-02-08 | Lackner Mark SVP, Head of Biology | Exercise or conversion · Stock Option (right to buy) | −300 | 34,714 | ||
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Exercise or conversion | +377 | $4.62 | $2K | 1,378 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Exercise or conversion | +1,123 | $6.98 | $8K | 2,501 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Sale | −1,701 | $18.30 | $31K | 800 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Sale | −800 | $18.79 | $15K | 0 |
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Exercise or conversion · Stock Option (right to buy) | −377 | 61,760 | ||
| 2021-01-26 | Lackner Mark SVP, Head of Biology | Exercise or conversion · Stock Option (right to buy) | −1,123 | 35,014 | ||
| 2020-06-17 | Lackner Mark SVP, Head of Biology | Exercise or conversion | +373 | $4.62 | $2K | 373 |
| 2020-06-17 | Lackner Mark SVP, Head of Biology | Sale | −373 | $19.91 | $7K | 0 |
| 2020-06-17 | Lackner Mark SVP, Head of Biology | Exercise or conversion · Stock Option (right to buy) | −373 | 62,137 |
Page 1 of 2 · 29 trades